Study directory

Depression studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
6115studies shown
Showing 3,301-3,312 of 6,115
Other study type icon
Not recruitingISRCTN17544090

The Morita study

This study is looking at whether a digital support tool can help People with current DSM depression, with or without DSM anxiety, Mental and Behavioural Disorders, or depression. Participants receive a study treatment and complete follow-up visits and assessments.

In United Kingdom
Why is this study shown?

This study is directly about Depression.

Depression, AnxietyOtherOver 18 Years
Countries
United Kingdom
Sponsor
University of Exeter
Condition
Depression, Anxiety
Other study type icon
Not recruitingISRCTN86292664

A community based group guided self-help intervention for low mood and stress

This study is looking at whether a digital support tool can help people with Depression, low mood, Mental and Behavioural Disorders, or Depressive episode, unspecified. Participants take part in a digital support tool and complete follow-up assessments.

In United Kingdom
Why is this study shown?

This study is directly about Depression.

DepressionOther
Countries
United Kingdom
Sponsor
University of Glasgow (UK)
Condition
Depression
Other study type icon
Not recruitingISRCTN18801971

VIVALDI Praxis: Valdoxan improves depressive symptoms and normalizes circadian rhythms

This observational study is following people with Episodes of major depression, Mental and Behavioural Disorders, or Recurrent depression to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

In Germany
Why is this study shown?

This study is directly about Depression.

DepressionOther
Countries
Germany
Sponsor
Servier Deutschland GmbH (Germany)
Condition
Depression
Drug study icon
CompletedEUCTR 2005-004006-81

A double-blind, 6 to 12-month, multicenter, multinational, randomized study evaluating the efficacy and safety of SR58611A (350 mg q12) versus placebo in the prevention of relapse / recurrence of d...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Czech Republic
Why is this study shown?

This study is directly about Depression.

DepressionDrugA study involving a medication or substance.
Countries
Czechia, Finland, Slovakia
Sponsor
sanofi-aventis recherche&developpement
Condition
Depression
Drug study icon
CompletedEUCTR 2014-004393-41

A double-blind, placebo-controlled study of the impact of prophylactic treatment with Galantamine 8mg of cognitive impairment during an electroconvulsive therapy (ECT) in patients with major depre...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Belgium
Why is this study shown?

This study is directly about Depression.

DepressionDrug
Countries
Belgium
Sponsor
CUB Hospital Erasme
Condition
Depression
Drug study icon
CompletedEUCTR 2016-003990-17

A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Sympto...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Bulgaria
Why is this study shown?

This study is directly about Depression.

DepressionDrug
Countries
Bulgaria, Germany, Hungary, ...
Sponsor
Janssen-Cilag International NV
Condition
Depression
Drug study icon
CompletedEUCTR 2011-002160-24

A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Investigate the Efficacy and Safety of RO4995819 Versus Placebo, as Adjunctive Therapy in Patients with Major D...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Austria
Why is this study shown?

This study is directly about Depression.

DepressionDrug
Countries
Austria, Germany, Slovakia
Sponsor
F. Hoffmann-La Roche Ltd.
Condition
Depression
Drug study icon
CompletedEUCTR 2005-003745-14

A Multi-centre, Double-blind, Randomised Withdrawal, Parallel-group, Placebo-controlled Phase III Study of the Efficacy and Safety of Quetiapine Fumarate Sustained Release (Seroquel SR®) as Monothe...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Finland
Why is this study shown?

This study is directly about Depression.

DepressionDrug
Countries
United Kingdom, Finland, Germany, ...
Sponsor
AstraZeneca AB
Condition
Depression
Drug study icon
CompletedEUCTR 2015-002007-29

A Phase 2a Randomized, Double-blind, Placebo-Controlled, Parallel-Group, Multi-center Study Investigating the Efficacy, Safety, and Tolerability of JNJ-42165279 in Subjects with Major Depressive Di...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Spain
Why is this study shown?

This study is directly about Depression.

Depression, AnxietyDrug
Countries
United Kingdom, Spain
Sponsor
Janssen-Cilag International NV
Condition
Depression, Anxiety
Drug study icon
TerminatedEUCTR 2019-002640-25

A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF THE EFFICACY AND SAFETY OF SAGE-217 WITH FIXED, REPEATED TREATMENT REGIMEN ON RELAPSE PREVENTION IN ADULTS WITH MAJOR DEPRESSIVE DIS...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Denmark
Why is this study shown?

This study is directly about Depression.

DepressionDrug
Countries
United Kingdom, Denmark, Spain
Sponsor
Sage Therapeutics, Inc.
Condition
Depression
Drug study icon
CompletedEUCTR 2009-017523-26

A randomised, double-blind, parallel-group, placebo-controlled, duloxetine-referenced, fixed-dose study evaluating the efficacy and safety of Lu AA21004 (15 and 20 mg/day) in the acute treatment of...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Belgium
Why is this study shown?

This study is directly about Depression.

DepressionDrug
Countries
Belgium, Estonia, Finland, ...
Sponsor
H. Lundbeck A/S
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.